Home
Ron Bentsur, Chairman & CEO: Nuvectis Pharma NVCT Buy · Filed 24/05/15
Trade details
- Type
- Insider buy
- Amount
- $13,075.6
- Shares · price
- 1,940 sh · $6.74 a share
- Held after
- 3,246,424 sh
- Stock
- Nuvectis Pharma NVCT
- Trade date
- 24/05/14
- Filed
- 24/05/15
- Days to filing
- 1 days
First buy since 2023
- Insiders buying this week
- 3 insiders
- Holding change
- +0.1%
Nuvectis Pharma trades, last 26 weeks
What else happened in Nuvectis Pharma around then
Filed or reported within 30 days of the trade day · 24/04/14~24/06/13Ron Bentsur's recent trades
- Ron Bentsur
BuyNuvectis Pharma
BuyNuvectis Pharma
NVCT
$28.6K
5,000 sh
$28.6K
Filed 25/11/06
Traded 25/11/05
- Ron Bentsur
BuyNuvectis Pharma
BuyNuvectis Pharma
NVCT
$20.9K
4,500 sh
$20.9K
Filed 24/12/26
Traded 24/12/24
- Ron Bentsur
BuyNuvectis Pharma
BuyNuvectis Pharma
NVCT
$98.4K
20,000 sh
$98.4K
Filed 24/11/18
Traded 24/11/15
- Ron Bentsur
BuyNuvectis Pharma
BuyNuvectis Pharma
NVCT
$12.8K
2,000 sh
$12.8K
Filed 24/05/13
Traded 24/05/10
- Ron Bentsur
BuyNuvectis Pharma
BuyNuvectis Pharma
NVCT
$51.5K
5,000 sh
$51.5K
Filed 24/03/19
Traded 24/03/18